section name header

Pronunciation

GLIP-i-zide audio

Indications

High Alert

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Well absorbed following oral administration.

Distribution: Unknown.

Protein Binding: 99%.

Metabolism/Excretion: Mostly metabolized by the liver.

Half-life: 2.1–2.6 hr.

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Derm: photosensitivity, rash.

Endo: hypoglycemia.

F and E: hyponatremia.

GI: constipation, cramps , diarrhea, drug-induced hepatitis, dyspepsia, appetite, nausea, vomiting.

Hemat: APLASTIC ANEMIA, agranulocytosis, hemolytic anemia, leukopenia, pancytopenia, thrombocytopenia.

Neuro: dizziness, drowsiness, headache, weakness.

Interactions

Drug-Drug:

Route/Dosage

Implementation

US Brand Names

Glucotrol, Glucotrol XL

Classifications

Therapeutic Classification: antidiabetics

Pharmacologic Classification: sulfonylureas

Availability

(Generic available)

Time/Action Profile

(hypoglycemic activity)

ROUTEONSETPEAKDURATION
PO15–30 min1–2 hrup to 24 hr

Assessment

Lab Test Considerations: Toxicity and Overdose:

Pot. Nursing Diagnoses

Patient/Family Teaching

Evaluation/Desired Outcomes

Code

NDC Code*